Join

Compare · BIMI vs CAH

BIMI vs CAH

Side-by-side comparison of BIMI International Medical Inc. (BIMI) and Cardinal Health Inc. (CAH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BIMI and CAH operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
  • CAH is the larger of the two at $47.89B, about 3443.8x BIMI ($13.9M).
  • CAH has hit the wire 1 time in the past 4 weeks while BIMI has been quiet.
  • CAH has more recent analyst coverage (25 ratings vs 0 for BIMI).
MetricBIMICAH
Company
BIMI International Medical Inc.
Cardinal Health Inc.
Price
$0.31-36.58%
$204.52-0.59%
Market cap
$13.9M
$47.89B
1M return
-
-
1Y return
-
-
Industry
Other Pharmaceuticals
Other Pharmaceuticals
Exchange
NASDAQ
NYSE
IPO
News (4w)
0
1
Recent ratings
0
25
BIMI

BIMI International Medical Inc.

BOQI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as NF Energy Saving Corporation and changed its name to BOQI International Medical Inc. in December 2019. BOQI International Medical Inc. was incorporated in 2000 and is based in Dalian, the People's Republic of China.

CAH

Cardinal Health Inc.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Latest BIMI

Latest CAH